International safety notice
TAFFIX espray nasal
Spain / AEMPS · ESP · Aug 13, 2021
Key facts
| Title | TAFFIX espray nasal |
|---|---|
| Regulator | Spain / AEMPS |
| Country | ESP |
| Brand | TAFFIX espray nasal |
| Manufacturer | Nasus Pharma, Ltd., Harakevet 29, Tel Aviv, 6618306, Israel |
| Models | D-30855, 2021-461, 91.822.52.89, 08195, 2021-140, COVID-19-QUE-HAN-SIDO-DETECTADOS-EN-EL-MERCADO-Y-NO-CUMPLEN-LA-REGULACION, 6618306, 28022, COVID-19 |
| Event type | Safety Notice |
| Date | Aug 13, 2021 |
| Regulator page | alertasps.aemps.es |
At a glance
- No Recall
- Yes Field safety notice
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1